SE401921B - Forfarande for framstellning av 15-alkyletrar av prostaglandiner av tup pgfŸ2 - Google Patents

Forfarande for framstellning av 15-alkyletrar av prostaglandiner av tup pgfŸ2

Info

Publication number
SE401921B
SE401921B SE7507801A SE7507801A SE401921B SE 401921 B SE401921 B SE 401921B SE 7507801 A SE7507801 A SE 7507801A SE 7507801 A SE7507801 A SE 7507801A SE 401921 B SE401921 B SE 401921B
Authority
SE
Sweden
Prior art keywords
pgfÿ2
alkylethers
tup
prostaglandins
procedure
Prior art date
Application number
SE7507801A
Other languages
English (en)
Swedish (sv)
Other versions
SE7507801L (sv
Inventor
Jr F H Lincoln
J E Pike
G A Youngdale
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE7507801L publication Critical patent/SE7507801L/xx
Publication of SE401921B publication Critical patent/SE401921B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P31/00Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7507801A 1971-05-04 1975-07-08 Forfarande for framstellning av 15-alkyletrar av prostaglandiner av tup pgfŸ2 SE401921B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14025171A 1971-05-04 1971-05-04

Publications (2)

Publication Number Publication Date
SE7507801L SE7507801L (sv) 1975-07-08
SE401921B true SE401921B (sv) 1978-06-05

Family

ID=22490405

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7507801A SE401921B (sv) 1971-05-04 1975-07-08 Forfarande for framstellning av 15-alkyletrar av prostaglandiner av tup pgfŸ2

Country Status (10)

Country Link
BE (1) BE783028A (xx)
CA (1) CA963900A (xx)
CH (2) CH566283A5 (xx)
DE (1) DE2221443A1 (xx)
FR (1) FR2135270A1 (xx)
HU (1) HU166654B (xx)
NL (1) NL7205997A (xx)
PL (1) PL88998B1 (xx)
SE (1) SE401921B (xx)
ZA (1) ZA722435B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100355A (en) * 1972-09-15 1978-07-11 The Upjohn Company 8β,12α-PGE2 -type compounds

Also Published As

Publication number Publication date
CH566283A5 (xx) 1975-09-15
DE2221443A1 (de) 1972-11-16
AU4154572A (en) 1973-11-01
CA963900A (en) 1975-03-04
ZA722435B (en) 1973-02-28
SE7507801L (sv) 1975-07-08
CH566284A5 (xx) 1975-09-15
BE783028A (fr) 1972-11-06
PL88998B1 (en) 1976-10-30
NL7205997A (xx) 1972-11-07
FR2135270A1 (en) 1972-12-15
FR2135270B1 (xx) 1976-05-14
HU166654B (xx) 1975-04-28

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE400548B (sv) Forfarande for framstellning av en substituerad bensoylester av en 1,8,9-trihydroxiantracen
SE382046B (sv) Forfarande for framstellning av 1-aryloxi-2-propanol
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
FI55994B (fi) Foerfarande foer framstaellning av 15 metylderivat av prostaglandin e2